Home > Healthcare > Medical Devices > Diagnostic Devices > Self-monitoring Blood Glucose Devices Market

Self-monitoring Blood Glucose Devices Market Analysis

  • Report ID: GMI2743
  • Published Date: Mar 2023
  • Report Format: PDF

Self-monitoring Blood Glucose Devices Market Analysis

Self-monitoring blood glucose devices market valuation from testing strips is estimated to reach over USD 13.5 billion by 2032. Test trips are available in a wide range of unit packs and under diverse brands. Glucose meters with test strips have emerged as the most commonly used blood glucose monitoring devices as they enable simple, fast, and convenient analysis. Furthermore, the easy availability of these test strips across e-commerce platforms is expected to boost the product sales. Moreover, blood glucose strips are disposable and coated with a biological enzyme to enable effective diabetes diagnosis.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for self-monitoring blood glucose devices was worth more than USD 24.3 billion in 2022 and is anticipated to expand at over 9.5% CAGR from 2023-2032.

Type 2 diabetes applications is poised to surpass USD 57.8 billion by 2032 driven by the increasing disease burden of type 2 diabetes.

Europe self-monitoring blood glucose devices market size is anticipated to exhibit 9.5% CAGR between 2023-2032 driven by the growing government initiatives to boost diabetes care.

Arkray, Inc., AgaMatrix, All Medicus Co., Ltd., Dexcom, Inc., Medtronic Plc, Sinocare Inc., Nova Biomedical, Inc., and DarioHealth Corp are some of the key providers of self-monitoring blood glucose devices.

Self-monitoring Blood Glucose Devices Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 285
  • Countries covered: 31
  • Pages: 182
 Download Free Sample